In addition to the much anticipated scientific programme, EASL Studio broadcasted LIVE from the congress, in Milan.
Programme
| 09:45 -10:15 CEST Buongiorno Milano: What not to miss during EASL Congress
Aleksander Krag (Moderator), Debbie Shawcross (Faculty), Thomas Berg (Faculty), Ahmed Elsharkawy (Faculty) |
| 13:15 – 13:45 CEST Advances in systemic treatments in liver cancer
Josep Llovet (Moderator), Massimo Iavarone (Faculty), Matthias Pinter (Faculty), Jessica Zucman-Rossi (Faculty) |
| 16:45 – 17:15 CEST MASLD anno 2024: A rapidly changing landscape
Sven Francque (Moderator), Asad Izzidin Dajani (Sanofi representative), Becky Taub (Madrigal Pharmaceuticals representative), Judith Ertle (Boehringer Ingelheim representative), This EASL Studio is supported by Boehringer Ingelheim, GSK, Madrigal Pharmaceuticals, NovoNordisk, and Sanofi
|
| 10:00 – 10:30 CEST Breaking boundaries: Innovating the future of hepatitis B and D treatment together
Thomas Berg (Moderator), Larry Blatt (Aligos representative), Todd Correll (VIR representative), Susan Dixon (GSK representative), Simon Fletcher (Gilead representative) This EASL Studio is supported by Aligos, Gilead, GSK and VIR
|
| 12:30 – 13:00 CEST Education at the heart of EASL’s mission
Sven Francque (Moderator), Krista Rombouts (Faculty), Rajeshwar Mookerjee (Faculty), Henning Grønbæk (Faculty) |
| 16:15 – 16:45 New therapeutic options and remaining challenges in PBC
Verena Keitel (Moderator), Carrie Frenette (Gilead representative), Tiago Nunes (Mirum representative), Dimitar Tonev (Ipsen representative), Phil Troke (GSK representative) This EASL Studio is supported by CymaBay Therapeutics, Gilead, GSK, IPSEN, and Mirum.
|
| 10:00 – 10:30 CEST SLD nomenclature: Need for refinement?
Aleksander Krag (Moderator), Meena Bansal (Faculty), Sven Francque (Faculty), Alexandre Louvet (Faculty) |
| 12:30 – 13:00 CEST Exploring new frontiers: The AI liver taskforce initiative
Eric Trépo (Moderator), Thomas Marjot (Faculty), Jakob Kather (Faculty), Raquel Pérez-López (Faculty) |
| 13:30 – 14:00 CEST Deciphering the drivers of cirrhosis decompensation: Opportunities for intervention and prevention
Debbie Shawcross (Moderator), Paolo Angeli (Faculty), Salvador Augustin (Boehringer Ingelheim representative), Paolo Caraceni (CSL Behring representative) This EASL Studio is supported by Boehringer Ingelheim, and CSL Behring |
| 16:30 – 17:00 CEST Unlocking breakthroughs: Pioneering drug development for ALD and MetALD
Aleksander Krag (Moderator), Mazen Noureddin (Faculty), Michelle Long (NovoNordisk representative), Nikhil Vergis (GSK representative) This EASL Studio is supported by Boehringer Ingelheim, GSK, Madrigal Pharmaceuticals, NovoNordisk, and Sanofi
|
| 12:30 – 13:00 CEST Landmark studies at EASL Congress 2024
Thomas Berg (Moderator), Rajiv Jalan (Faculty), Verena Keitel (Faculty), Frank Tacke (Faculty) |
| 15:45 – 16:15 CEST Arrivederci Milano, hallo Amsterdam!
Aleksander Krag (Moderator), Debbie Shawcross (Moderator), Cyrielle Caussy (Faculty), Ana Lleo (Faculty), Jean-Charles Nault (Faculty), Francesco Negro (Faculty), Vlad Ratziu (Faculty), Virginia Hernández-Gea (Faculty) |